Clinics and Research in Hepatology and Gastroenterology

Aims & Scope

Clinics and Research in Hepatology and Gastroenterology publishes high-quality original research papers in the field of hepatology and gastroenterology.

The editors put the accent on rapid communication of new research and clinical developments and so called "hot topic" issues.

Following a clear Editorial line, besides original articles and case reports, each issue features editorials, commentaries and reviews.

The journal encourages research and discussion between all those involved in the specialty on an international level.

All articles are peer reviewed by international experts, the articles in press are online and indexed in the international databases (Current Contents, Pubmed, Scopus, Science Direct).

Clinics and Research in Hepatology and Gastroenterology is a subscription journal (with optional open access), which allows you to publish your research without any cost to you (unless you proactively chose the open access option).

Your article will be available to all researchers around the globe whose institution has a subscription to the journal.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.4
2024	2.60

Journal Rank

Year	Value
2024	7372

Journal Citation Indicator

Year	Value
2024	1303

SJR (SCImago Journal Rank)

Year	Value
2024	0.752

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	70

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role

  Citation: 238

  Authors: J., K., L., M.A., B.

• The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®

  Citation: 229

  Authors: M., V., L., M.

• Reversibility of liver fibrosis

  Citation: 201

  Authors: Mengxi, Tatiana

• Progressive familial intrahepatic cholestasis

  Citation: 179

  Authors: Emmanuel

• Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action

  Citation: 177

  Authors: Raoul

• The bile salt export pump (BSEP) in health and disease

  Citation: 161

  Authors: Ralf, Carola, Jan, Katrin, Dieter

• The pathophysiology of intrahepatic cholestasis of pregnancy

  Citation: 154

  Authors: Peter H., Catherine

• Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity

  Citation: 143

  Authors: Serkan, Bilge Demirel, Burak, Hakan, Adnan, Abdurrahim, Yasemin Ozin, Yavuz, Ertugrul

• Porphyrias: A 2015 update

  Citation: 133

  Authors: Zoubida, Said, Gael, Jean-Charles, Laurent, Hervé

• Systematic review of progressive familial intrahepatic cholestasis

  Citation: 118

  Authors: Alastair, Nanda, Lora, Binita M., Roderick H.J.

---